Health & Medicine · Clinical Dosing · Antibiotic Dosing
Vancomycin Dosing Calculator
Calculates weight-based vancomycin initial dosing and dosing interval recommendations based on patient weight, renal function, and indication.
Calculator
Formula
The initial vancomycin dose is calculated as 15–20 mg/kg of total body weight (TBW) for serious infections, or 25–30 mg/kg for severe MRSA infections such as bacteremia or endocarditis, with a typical single dose cap of 3000 mg. Creatinine clearance (CrCl) is estimated using the Cockcroft-Gault equation, where Age is in years, Weight is actual body weight in kilograms, and SCr is serum creatinine in mg/dL. The CrCl result is multiplied by 0.85 for female patients. Dosing interval is then selected based on CrCl: every 6–8 hours for CrCl ≥ 90, every 12 hours for CrCl 50–89, every 24 hours for CrCl 20–49, and every 48–96 hours for CrCl < 20 mL/min.
Source: Rybak MJ et al. Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections. American Journal of Health-System Pharmacy, 2020; ASHP/IDSA/SIDP Vancomycin Consensus Guidelines.
How it works
Vancomycin is a concentration-independent (time-dependent) antibiotic whose efficacy correlates with the AUC/MIC ratio. The 2020 ASHP/IDSA/SIDP consensus guidelines recommend targeting an AUC of 400–600 mg·h/L for serious MRSA infections, replacing the older trough-only approach. Initial dosing, however, is still calculated using weight-based formulas before individual pharmacokinetic monitoring guides subsequent doses.
The initial dose is computed as a fixed number of milligrams per kilogram of total body weight (TBW): typically 15–20 mg/kg for standard serious infections and up to 25–30 mg/kg for life-threatening MRSA infections such as bacteremia or endocarditis, with a practical maximum single dose of approximately 3000 mg to limit infusion-related adverse effects. Renal function is assessed using the Cockcroft-Gault equation: CrCl = [(140 − Age) × Weight] / (72 × SCr), multiplied by 0.85 for females. The calculated CrCl determines the appropriate dosing interval — every 8 hours for CrCl ≥ 90 mL/min, every 12 hours for CrCl 50–89 mL/min, every 24 hours for CrCl 20–49 mL/min, and every 48 hours or longer for CrCl below 20 mL/min.
This calculator is most useful in the acute inpatient setting, where rapid, bedside estimation of an appropriate starting regimen is needed before serum vancomycin levels are measured. It is routinely applied in emergency departments, surgical ICUs, infectious disease consultations, and general ward pharmacokinetic monitoring programs. Obese patients, pediatric patients, critically ill patients with augmented renal clearance, and patients on renal replacement therapy require specialized adjustment beyond what a standard weight-based calculation provides.
Worked example
Consider a 58-year-old male patient weighing 82 kg with a serum creatinine of 1.3 mg/dL, admitted with suspected MRSA bacteremia.
Step 1 — Estimate CrCl using Cockcroft-Gault:
CrCl = [(140 − 58) × 82] / (72 × 1.3)
CrCl = [82 × 82] / 93.6
CrCl = 6724 / 93.6 ≈ 71.8 mL/min
Step 2 — Select dose per kg for indication:
For severe MRSA bacteremia, use 25 mg/kg.
Single dose = 25 × 82 = 2050 mg (within the 3000 mg cap).
Step 3 — Select dosing interval:
CrCl of 71.8 mL/min falls in the 50–89 range → dosing interval = every 12 hours.
Step 4 — Calculate total daily dose:
Daily dose = 2050 mg × (24 ÷ 12) = 4100 mg/day.
The recommended initial regimen is therefore 2050 mg IV every 12 hours, infused over at least 90–120 minutes to reduce the risk of Red Man Syndrome. Serum vancomycin levels (or AUC monitoring) should be obtained after the third dose to guide further adjustments.
Limitations & notes
This calculator provides weight-based initial dose estimates only and should not replace therapeutic drug monitoring (TDM) or individualized pharmacokinetic analysis. The Cockcroft-Gault equation used for CrCl estimation assumes stable renal function — it is unreliable in patients with acute kidney injury, rapidly fluctuating creatinine, extremes of age, severe muscle wasting, or morbid obesity. For obese patients, adjusted body weight (AdjBW) is often preferred over TBW to avoid overdosing. Patients with augmented renal clearance (ARC), commonly seen in young trauma patients and critically ill patients, may require higher doses or shorter intervals than predicted. Vancomycin dosing in pediatric patients follows different weight-based standards (40–60 mg/kg/day) and is not represented here. Patients on continuous renal replacement therapy (CRRT) or hemodialysis require institution-specific supplemental dosing protocols. Always verify recommendations against current institutional guidelines and consult a clinical pharmacist for complex cases. This tool is intended for educational and clinical decision-support purposes only and does not constitute medical advice.
Frequently asked questions
What is the standard vancomycin dose per kg for adults?
For most serious gram-positive infections, the standard initial vancomycin dose is 15–20 mg/kg of total body weight per dose, administered every 8–12 hours depending on renal function. For life-threatening MRSA infections such as bacteremia or endocarditis, guidelines support loading doses of 25–30 mg/kg, though individual doses are typically capped at 3000 mg to limit toxicity.
How does creatinine clearance affect vancomycin dosing intervals?
Vancomycin is eliminated almost exclusively by the kidneys, so reduced creatinine clearance (CrCl) prolongs its half-life and requires extending the dosing interval. Patients with CrCl ≥ 90 mL/min typically dose every 8 hours; CrCl 50–89 every 12 hours; CrCl 20–49 every 24 hours; and CrCl below 20 mL/min may only require dosing every 48–96 hours.
Should total body weight or ideal body weight be used for vancomycin dosing in obese patients?
Current guidelines generally recommend using total body weight (TBW) for initial vancomycin dosing in obese patients, as the volume of distribution correlates with TBW. However, to avoid supratherapeutic doses, many institutions use adjusted body weight (AdjBW = IBW + 0.4 × [TBW − IBW]) in patients who are significantly obese (BMI > 40). Close TDM is essential in obese patients regardless of the weight used.
What are the target vancomycin levels for MRSA infections?
The 2020 ASHP/IDSA/SIDP guidelines recommend targeting a vancomycin AUC/MIC ratio of 400–600 mg·h/L for serious MRSA infections, using Bayesian pharmacokinetic software for AUC-guided monitoring. If trough-only monitoring is still used, target troughs of 15–20 mg/L are recommended for serious infections, though this approach has fallen out of favor due to nephrotoxicity risk.
How long does it take for vancomycin to reach steady state?
Vancomycin reaches steady-state plasma concentrations after approximately four to five half-lives. In patients with normal renal function (half-life ~6 hours), steady state is achieved within 24–30 hours. In patients with renal impairment, the half-life can extend to 30–200 hours, significantly delaying steady state and making early TDM after a loading dose particularly valuable.
Last updated: 2025-01-15 · Formula verified against primary sources.